Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Collective assessment of antimicrobial susceptibility among the most common Gram-negative respiratory pathogens driving therapy in the ICU.
Moise PA, Gonzalez M, Alekseeva I, Lopez D, Akrich B, DeRyke CA, Chen WT, Pavia J, Palermo B, Hackel M, Motyl M. Moise PA, et al. Among authors: deryke ca. JAC Antimicrob Resist. 2021 Feb 19;3(1):dlaa129. doi: 10.1093/jacamr/dlaa129. eCollection 2021 Mar. JAC Antimicrob Resist. 2021. PMID: 34223078 Free PMC article.
Ceftolozane/Tazobactam and Imipenem/Relebactam Cross-Susceptibility Among Clinical Isolates of Pseudomonas aeruginosa From Patients With Respiratory Tract Infections in ICU and Non-ICU Wards-SMART United States 2017-2019.
Lob SH, DePestel DD, DeRyke CA, Kazmierczak KM, Young K, Motyl MR, Sahm DF. Lob SH, et al. Among authors: deryke ca. Open Forum Infect Dis. 2021 Jun 16;8(7):ofab320. doi: 10.1093/ofid/ofab320. eCollection 2021 Jul. Open Forum Infect Dis. 2021. PMID: 34307727 Free PMC article.
In vitro activity of ceftolozane/tazobactam against Gram-negative isolates collected from ICU patients with lower respiratory tract infections in seven Asian countries-SMART 2017-2019.
Lob SH, Kazmierczak KM, Chen WT, Siddiqui F, DeRyke CA, Young K, Motyl MR, Sahm DF. Lob SH, et al. Among authors: deryke ca. J Glob Antimicrob Resist. 2022 Jun;29:527-533. doi: 10.1016/j.jgar.2021.11.011. Epub 2021 Dec 8. J Glob Antimicrob Resist. 2022. PMID: 34896336 Free article.
In Vitro Activity of Ceftolozane-Tazobactam, Imipenem-Relebactam, Ceftazidime-Avibactam, and Comparators against Pseudomonas aeruginosa Isolates Collected in United States Hospitals According to Results from the SMART Surveillance Program, 2018 to 2020.
Karlowsky JA, Lob SH, DeRyke CA, Hilbert DW, Wong MT, Young K, Siddiqui F, Motyl MR, Sahm DF. Karlowsky JA, et al. Among authors: deryke ca. Antimicrob Agents Chemother. 2022 May 17;66(5):e0018922. doi: 10.1128/aac.00189-22. Epub 2022 May 2. Antimicrob Agents Chemother. 2022. PMID: 35491836 Free PMC article.
Activity of ceftolozane/tazobactam against clinical isolates of Pseudomonas aeruginosa from patients in the Middle East and Africa - Study for Monitoring Antimicrobial Resistance Trends (SMART) 2017-2020.
Lob SH, Estabrook MA, DeRyke CA, Alekseeva I, Siddiqui F, Young K, Motyl MR, Sahm DF. Lob SH, et al. Among authors: deryke ca. Int J Infect Dis. 2022 Dec;125:250-257. doi: 10.1016/j.ijid.2022.10.014. Epub 2022 Oct 14. Int J Infect Dis. 2022. PMID: 36244599 Free article.
47 results